AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

AACC Academy Distinguished Abstracts Winners

The AACC Academy is pleased to announce the winners of the 2020 Distinguished Abstracts Awards. A group of Fellows selected these 31 abstracts for their scientific excellence from a pool of 733 abstracts accepted for the AACC Annual Scientific Meeting. Winning abstracts will display the Academy blue ribbon during the virtual AACC Annual Scientific Meeting poster sessions.

A-005 Reinhardt Hesse, Johannesburg, South Africa
Machine Learning Outperforms Traditional Screening and Diagnostic Tools for the Detection of Familial Hypercholesterolaemia

A-023 Eunhee Nah, Seoul, Republic of Korea
Usefulness of the Urine Dipstick Albumin to Creatinine Ratio and Dipstick Proteinuria for Screening of Chronic Kidney Disease in Health Checkups

A-105 Kristin Mullins, Baltimore, MD
Impact of Co-Morbidities on Temporal Changes 2-4 Hours after Presentation in Subjects with cTnI Values above the 99th Percentile

A-125 Zhimin (Tim) Cao
CLIA (2019 Proposed) Proficiency Testing Criteria for HbA1c - 5% vs 10% or in-between?

A-134 Mark Kushnir, Salt Lake City, UT
LC-MS/MS Measurements of PTHrP Revealed Higher Prevalence of PTHrP caused Hypercalcemia in Men than Women

A-143 Zhimin (Tim) Cao
Accuracy-Based Assessment of Estradiol Measurement Procedures

A-181 Christine Dolin, Lexington, KY
Bone Biomarkers Predict High Turnover vs. Low Turnover Osteoporosis

A-200 Blanca Dehesa, San Mateo de Gállego, Spain
New Alternatives for the Simultaneous Detection of Several Pathogens involved in Sexually Transmitted Diseases (STIs)

A-201 Ekkehard Schütz, Göttingen, Germany
Time Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients between One and Five Years following Kidney Transplantation

A-209 Nga Yeung Tang, Chicago, IL
Evaluation of a Pharmacogenomics Panel on the TaqMan OpenArray Genotyping Platform

A-213 Lingxia Jiang, Palo Alto, CA
Development and Validation of a Multiplexing Digital PCR Spinal Muscular Atrophy (SMA) Screening Assay on a Novel Integrated Digital PCR Instrument

A-220 Irene De Biase, Salt Lake City, UT
Laboratory Findings in a Large Cohort of Patients with Homocysteine Remethylation Disorders and Cystathionine-Beta-Synthase Deficiency

A-264 Roya Sheybani, San Francisco, CA
Rapidly Assessing the Host Immune Response for the Diagnosis of Sepsis, a Prospective Multi-Site Clinical Study in the Emergency Department (ED) Employing the Leukocyte Structural Index (LSI)

A-306 Mary Kathryn Bohn, Toronto, ON, Canada
Pediatric Reference Intervals for Critical Point of Care Assays in the CALIPER Cohort of Healthy Children and Adolescents

A-345 Ioannis Papassotiriou, Athens, Greece
Clinical Value of Serum Amyloid A (SAA) Protein, High Density Lipoprotein-Cholesterol (HDL-C) and Apolipoprotein-A1 (Apo-A1) in the Diagnosis and Follow-Up of Neonatal Sepsis

A-367 Lingxia Jiang, Palo Alto, CA
A 4-Color Multiplexing Digital PCR Assay for Non-Invasive Prenatal Trisomy Testing Using a Novel Digital PCR Platform

B-006 Erica Fatica, Rochester, MN
Seeing Double: MASS-FIX Characterization of Immunofixation Bands as Monoclonal or Biclonal

B-018 Viola Borchardt-Lohölter, Lübeck, Germany
Identification of DAGLA as an Autoantibody Target in Cerebellar or Hippocampal Degeneration

B-055 Katie Thoren, New York, NY
A Validation Study of a Novel poly-MALDI-TOF-MS Assay for the Detection of Monoclonal Proteins

B-060 Seung-Jung Kee, Gwangju, Republic of Korea
Biomarkers for Detection of Mycobacterium Tuberculosis Infection in Supernatant of QuantiFERON Gold In-Tube and Gold Plus

B-096 Ioannis Papassotiriou, Athens, Greece
Soluble P-Selectin Levels in Patients with Sickle Cell Disease Reflect Platelets’ Activation Rather than Endothelial Dysfunction

B-103 Mayukh Sarkar, Milwaukee, WI
Diagnostic Management of Errors in Clinical Laboratory Test Selection

B-149 Emily Garnett, Houston, TX
Comparison of Three Calculation Methods of Low Density Lipoprotein-Cholesterol: Results from the Multi-Ethnic Study of Atherosclerosis

B-156 Yasuki Ito, Tokyo, Japan
Smoking Adversely Affects Lipoprotein Profile by Causing Specific Increase in Atherogenic Small, Dense LDL-C Level

B-203 Douglas Stickle, Philadelphia, PA
Use of Electronic Text Processing for Automated, Paperless Review of Daily Quality Assurance Reports Generated by the Laboratory Information System

B-210 Lokinendi Rao, Marlboro, MA
Large-Scale Retrospective Analyses of the Effect of Iron Deficiency Anemia on Hemoglobin A1c Levels

B-237 Uttam Garg, Kansas City, MO
Simple Tool to Identify Intravenous (IV) Fluid Contamination through Glucose Measurement

B-238 Vinita Thakur, St. John’s, NL, Canada
Use of a Lean Six Sigma Approach to Investigate Excessive Quality Control Material Use and Resulting Costs

B-268 Y. Ruben Luo, San Francisco, CA
Exploration of Applying High-Resolution MS2/MS3 Mass Spectrometry for Screening Toxic Natural Products

B-311 Swarnima Singh, Patna, India
Clinical Significance of Circulating Tumor Cells in Ovarian Cancers

B-339 Danielle Zauli, Vespasiano, Brazil
Frequency of Variants in the BRCA1 and BRCA2 Genes in Patients without a Family History of Breast and/or Ovarian Cancer

AACC Academy Designation

Fellows of AACC Academy use the designation of FAACC. This designation is equivalent to FACB, the previous designation used by fellows of the National Academy of Clinical Biochemistry, which became AACC Academy in 2016.